Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.32    -0.005 (-1.54%)
Bid:
0.31
Ask:
0.33
Spread: 0.02 (6.452%)
Market Cap: £24.88m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Functionalised Masterbatch Used in Bolflex Sole

9 Feb 2021 07:00

RNS Number : 4333O
Haydale Graphene Industries PLC
09 February 2021
 

 

REACH

 

For immediate release

09 February 2021

 

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

Haydale's Functionalised Nano-Enhanced Rubber Masterbatch Used in Bolflex Rubber Sole

 

Haydale, (AIM: HAYD), the global advanced materials group, is pleased to announce that Bolflex has purchased 80 kg of its functionalised nano-enhanced rubber masterbatch for use in its premium soles range for shoe production. This follows Haydale recently increasing the elastomer capability of its functionalised nano-enhanced rubber masterbatch.

Haydales' products are incorporated into the styrene-butadiene rubber (SBR) compound offering increased tear strength, abrasion resistance, flex resistance, slip resistance and coefficient of friction - all essential properties for footwear.

The initial order of 80 kg enabled Bolflex, to prepare 3,000 pairs of functionalised nano-enhanced rubber soles and Bolflex are currently evaluating the performance of their nano-enhanced shoe sole product against their competitor's products. Initial results are demonstrating improvements against its footwear specific test standards. The Group expects to receive follow up orders during 2021.

According to Lucintel, the global footwear sole material market is expected to reach $21.0 billion by 2023. Bolflex is a market leading company, specialising in the production and supply of soles for the European footwear industry. It is now one of the largest manufacturers of the Iberian Peninsula and Europe with an existing capacity to manufacture around 20,000 pairs a day.

Pedro Saraiva, Head of Sales at Bolflex, said: "We have evaluated a number of nanomaterial products prior to purchasing Haydale's product and noted a dramatic step-change improvement as a direct result of the proprietary functionalisation process. This has shown improvements in the handling, dispersion and overall performance of the nanomaterials when mixed into rubber compounds."

Keith Broadbent, Haydale CEO, said: "We are really pleased to be working with Bolflex on this product and look forward to seeing the Haydale logo on the soles of shoes produced."

 

 

- Ends -

 

 

 

 

For further information:

Haydale Graphene Industries plc

 

Keith Broadbent, CEO

Tel: +44 (0) 1269 842 946

Gemma Smith, Global Head of Marketing

 

 

Arden Partners plc (Nominated Adviser & Broker)

 

Ruari McGirr / Paul Shackleton / Ben Cryer

Tel: +44 (0) 20 7614 5900

 

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness through its state-of-the-art functionalisation. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from six sites in the UK, USA and the Far East.

For more information please visit: www.haydale.com 

Twitter: @haydalegraphene 

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADZGGZVLLGMZG
Date   Source Headline
19th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
14th Mar 20197:00 amRNSDirector/PDMR Shareholding
12th Mar 201911:19 amRNSResult of General Meeting
12th Mar 20197:00 amRNSResult of Open Offer
1st Mar 201912:04 pmRNSHolding(s) in Company
27th Feb 20192:00 pmRNSPrice Monitoring Extension
26th Feb 20191:34 pmRNSHolding(s) in Company
22nd Feb 20194:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Feb 201912:54 pmRNSResult of Placing and Subscription
22nd Feb 201911:05 amRNSSecond Price Monitoring Extn
22nd Feb 201911:00 amRNSPrice Monitoring Extension
22nd Feb 20197:01 amRNSProposed Placing and Open Offer
22nd Feb 20197:00 amRNSInterim Results
20th Feb 20192:06 pmRNSSecond Price Monitoring Extn
20th Feb 20192:00 pmRNSPrice Monitoring Extension
20th Feb 20199:00 amRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSComment on Speculation
21st Jan 20197:00 amRNSHolding(s) in Company
15th Jan 20197:21 amRNSAgreement for Functionalised Piezoresistive Ink
14th Jan 20197:00 amRNSDirector/PDMR Shareholding
14th Jan 20197:00 amRNSHolding(s) in Company
7th Jan 20194:15 pmRNSFurther re Issue of Equity
4th Jan 201911:51 amRNSDirector/PDMR Shareholding
28th Dec 20187:00 amRNSPDMR Shareholding
21st Dec 201812:22 pmRNSResult of AGM
21st Dec 20187:00 amRNSFinance facility, issue of equity, director change
30th Nov 20184:35 pmRNSPrice Monitoring Extension
29th Nov 20187:00 amRNSUpdate on functionalised graphene ink sales
29th Nov 20187:00 amRNSAnnual Report & Notice of AGM
27th Nov 20189:31 amRNSGEIC to join Haydale and Wheelsure collaboration
27th Nov 20189:05 amRNSSecond Price Monitoring Extn
27th Nov 20189:00 amRNSPrice Monitoring Extension
26th Nov 20184:40 pmRNSSecond Price Monitoring Extn
26th Nov 20184:35 pmRNSPrice Monitoring Extension
19th Nov 20187:00 amRNSLicense agreement for anti-counterfeiting product
13th Nov 20187:00 amRNSJoint Development Agreement with Star RFID
12th Nov 201812:40 pmEQSHardman & Co Research: Haydale (HAYD): Enlightenment delayed
9th Nov 20187:00 amRNSFinancing Update
12th Oct 20187:00 amRNSDevelopment funding from Niche Vehicle Network
28th Sep 20182:54 pmRNSDirector Dealing
27th Sep 20189:29 amRNSNOTIFICATION OF MAJOR HOLDINGS
26th Sep 20185:21 pmEQSHardman & Co Research: Haydale (HAYD): Exuberance, reality; enlightenment now to follow
18th Sep 20187:00 amRNSDevelopment Contract with the EIS
18th Sep 20187:00 amRNSFull Year Results
11th Sep 20187:00 amRNSContract Updates & Notice of Results
5th Sep 20187:00 amRNSBoard Changes
13th Aug 20187:00 amRNSDirector Dealing
8th Aug 20183:01 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.